Revelation Biosciences, Inc.
REVB
$0.93
-$0.02-2.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.91M | -2.44M | -2.05M | -1.73M | -2.24M |
| Total Depreciation and Amortization | 6.80K | 7.20K | 7.20K | 7.20K | 7.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.70K | 800.00 | 228.80K | 70.00K | 26.10K |
| Change in Net Operating Assets | 306.80K | 517.10K | -979.30K | -2.10M | -7.05M |
| Cash from Operations | -1.59M | -1.92M | -2.79M | -3.75M | -9.26M |
| Capital Expenditure | -- | -- | -- | 17.70K | -17.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 17.70K | -17.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.12M | 3.39M | -- | 3.69M | 3.74M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.12M | 3.39M | -- | 3.69M | 3.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.53M | 1.47M | -2.79M | -42.00K | -5.53M |